arzerra - ofatumumab injection, solution
(Ofatumumab)Novartis Pharmaceuticals Corporation
CD20-directed Cytolytic Antibody [EPC] class drugs
8 results
briumvi - ublituximab injection, solution, concentrate
(Ublituximab)Tg Therapeutics, Inc.kesimpta - ofatumumab injection, solution
(Ofatumumab)Novartis Pharmaceuticals Corporationocrevus - ocrelizumab injection
(Ocrelizumab)Genentech, Inc.Usage: OCREVUS is indicated for the treatment of relapsing forms of multiple sclerosis (including clinically isolated syndrome, relapsing-remitting, and active secondary progressive MS) and primary progressive MS in adults.ocrevus zunovo - ocrelizumab and hyaluronidase injection, solution
(Ocrelizumab And Hyaluronidase)Genentech, Inc.Usage: OCREVUS ZUNOVO is indicated for treating relapsing forms of multiple sclerosis (MS) in adults, including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, as well as primary progressive MS.riabni - rituximab - arrx injection, solution
(Rituximab-Arrx)Amgen, Incruxience - rituximab - pvvr injection, solution
(Rituximab-Pvvr)Pfizer Laboratories Div Pfizer Inctruxima - rituximab - abbs injection, solution
(Rituximab-Abbs)Cephalon, Inc.